Skip to main content

Table 4 Demographics and clinical characteristics of proactive physical therapy users in years 1 and 3

From: Sustainment of proactive physical therapy for individuals with early-stage Parkinson’s disease: a quality improvement study over 4 years

 

Year 1 (n = 28)

Year 3 (n = 62)

t-value or X2 (DF)

p-valuea

Age [mean years (SD)]

65.1 (11.2)

65.8 (9.1)

t (88 DF) = − 0.30,

p = 0.761

Male [n (%)]

16 (57%)

37 (59%)

X2 (1 DF) = 0.05

p = 0.821

UPDRS [mean (SD)]

16.2 (6.8)

23.2 (12.0)

t (50.7 DF) = − 2.78

p = 0.0076

Missinga

0

30

  

Hoehn and Yahr stage

 

X2 (2 DF) = 1.75

p = 0.418

1

5 (18%)

9 (15%)

  

2

23 (82%)

23 (37%)

  

3

0 (0%)

1 (2%)

  

Missinga

0 (%)

29 (47%)

  

Time since diagnosis

X2 (4 DF) = 9.25

p = 0.055

< 1 month

14 (50%)

12 (19%)

  

1–6 months

4 (14%)

19 (31%)

  

6-12 months

4 (14%)

8 (13%)

  

1–2 years

3 (11%)

7 (11%)

  

2+ years

3 (11%)

13 (21%)

  

Missing a

0 (0%)

3 (5%)

  

Time since symptoms

X2 (3 DF) = 9.06

p = 0.029

< 1 month

0 (0%)

0 (0%)

  

1–6 months

5 (18%)

1 (2%)

  

6–12 months

5 (18%)

11 (18%)

  

1–2 years

5 (18 %)

20 (32%)

  

2+ years

13 (46%)

23 (37%)

  

Missing a

0 (0%)

7 (11%)

  

Insurance

  

X2 (2 DF) = 1.14

p = 0.565

Medicare

15 (54%)

29 (47%)

  

Blue Cross Blue Shield

9 (32%)

18 (29%)

  

Other

4 (14%)

15 (26%)

  
  1. aMissing data were excluded from analyses (UPDRS and Hoehn and Yahr were missing from provider referral notes)